<?xml version="1.0" encoding="UTF-8"?>
<p>Key information is represented by the lack of clinically significant interaction between RDV and other classes of drugs used as comedication for COVID-19 patients as analgesics, antiarrhythmics, antibacterials, anticoagulants, anti-platelets and fibrinolytics, antidiabetics, antifungals, anti-hypertensives (ACE inhibitors, angiotensin antagonists, diuretics, other agents), neuroleptics/antipsychotics, other antivirals for COVID-19 treatment, anxiolytics/hypnotics/sedatives, beta blockers, bronchodilators, calcium channel blockers, contraceptives, gastrointestinal agents, anti-emetics, hormone replacement therapy, immunosuppressants, inotropes and vasopressors, lipid lowering agents, and steroids [
 <xref rid="B80-jcm-09-02084" ref-type="bibr">80</xref>].
</p>
